BNTC
BENITEC BIOPHRM (BNTC)
NASDAQ
$13.00+$0.005 (+0.04%)
Price as of Jul 13, 2026 6:18 PM EDT
  • $446.3M
    Market Cap
  • -1.96%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2025
06/30/2024
06/30/2023
06/30/2021
Income Statement
Total Operating Revenue
0
+100.00%
-1,000
-66.67%
-3,000
-105.08%
59,000
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
+100.00%
-1,000
-66.67%
-3,000
-105.08%
59,000
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-18.3M
+17.45%
-15.6M
+22.19%
-12.8M
+81.97%
-7.0M
N/A
Depreciation and Amortization Expense
66,000
-24.14%
87,000
-36.03%
136,000
-41.13%
231,000
N/A
Total Operating Expenses
41.8M
+85.70%
22.5M
+17.40%
19.2M
+40.29%
13.7M
N/A
Operating Profit
-41.8M
+85.70%
-22.5M
+17.87%
-19.1M
+40.34%
-13.6M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
-33,000
+450.00%
-6,000
N/A
Interest Income and Expense and Net
0
N/A
0
+100.00%
-33,000
+450.00%
-6,000
N/A
Total Nonoperating Income and Expense
3.8M
+420.70%
739,000
+253.64%
-481,000
+68.18%
-286,000
N/A
Income before Taxes
-37.9M
+69.50%
-22.4M
+17.24%
-19.1M
+40.34%
-13.6M
N/A
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-37.9M
+74.32%
-21.8M
+11.19%
-19.6M
+40.92%
-13.9M
N/A
Net Income from Continuing Operations Applicable to Common
-37.9M
+69.50%
-22.4M
+14.35%
-19.6M
+40.92%
-13.9M
N/A
Basic EPS and Net Income
-1.05
-80.94%
-5.51
-60.98%
-14.12
+337.15%
-3.23
N/A
Diluted EPS and Net Income
-1.05
-80.94%
-5.51
-60.98%
-14.12
+337.15%
-3.23
N/A
Basic Weighted Average Shares
36.2M
+791.81%
4.1M
+192.98%
1.4M
-67.74%
4.3M
N/A
Diluted Weighted Average Shares
36.2M
+791.81%
4.1M
+192.98%
1.4M
-67.74%
4.3M
N/A
Balance Sheet
Cash and Cash Equivalents
97.7M
+92.16%
50.9M
+1,953.53%
2.5M
-87.47%
19.8M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
97.7M
+92.16%
50.9M
+1,953.53%
2.5M
-87.47%
19.8M
N/A
Total Current Assets
98.5M
+90.65%
51.7M
+1,285.73%
3.7M
-81.91%
20.6M
N/A
Accumulated Depreciation
1.5M
+4.70%
1.4M
+6.53%
1.3M
+29.47%
1.0M
N/A
Property and Plant and Equipment and Net
131,000
-26.82%
179,000
+105.75%
87,000
-76.80%
375,000
N/A
Total Long-Term Assets
131,000
-26.82%
179,000
+105.75%
87,000
-52.97%
185,000
N/A
Total Assets
99.6M
+90.75%
52.2M
+1,069.58%
4.5M
-79.12%
21.4M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
1.8M
-63.40%
4.9M
+23.78%
4.0M
+190.58%
1.4M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
495,000
N/A
0
-100.00%
284,000
+33.33%
213,000
N/A
Total Liabilities
2.3M
-53.71%
5.0M
+16.42%
4.3M
+211.32%
1.4M
N/A
Retained Earnings
-228.2M
+19.93%
-190.3M
+13.32%
-167.9M
+29.03%
-130.1M
N/A
Total Stockholders Equity
97.3M
+105.92%
47.2M
+23,290.10%
202,000
-98.99%
20.0M
N/A
Total Shares Outstanding
26.3M
+1,470.49%
1.7M
+1.55%
1.6M
-79.86%
8.2M
N/A
Cash Flow
Cash from Operating Activities
-23.6M
+21.57%
-19.4M
+7.72%
-18.0M
+40.37%
-12.8M
N/A
Capital Expenditures
18,000
-89.94%
179,000
+17,800.00%
1,000
-99.55%
221,000
N/A
Cash from Investing Activities
-18,000
-89.94%
-179,000
+17,800.00%
-1,000
-99.55%
-221,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
70.5M
+3.61%
68.0M
+324.78%
16.0M
-28.89%
22.5M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
2,249,000.00%
+253.60%
636,033.33%
N/A
N/A
N/A
Return on Assets
N/A
N/A
-76.76%
-49.30%
-151.39%
N/A
N/A
N/A
Return on Equity
N/A
N/A
-91.68%
-52.64%
-193.57%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
66.67%
+163.44%
-105.08%
N/A
N/A
N/A
Current Ratio
N/A
N/A
10.49
+1,019.51%
0.94
N/A
N/A
N/A
Cash Ratio
N/A
N/A
10.33
+1,558.94%
0.62
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow